Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 8
1994 21
1995 28
1996 20
1997 37
1998 23
1999 32
2000 42
2001 40
2002 48
2003 41
2004 47
2005 49
2006 57
2007 66
2008 60
2009 64
2010 71
2011 59
2012 71
2013 75
2014 80
2015 75
2016 88
2017 108
2018 76
2019 89
2020 78
2021 65
2022 18
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,461 results

Results by year

Filters applied: . Clear all
Page 1
NTRK fusion-positive cancers and TRK inhibitor therapy.
Cocco E, Scaltriti M, Drilon A. Cocco E, et al. Nat Rev Clin Oncol. 2018 Dec;15(12):731-747. doi: 10.1038/s41571-018-0113-0. Nat Rev Clin Oncol. 2018. PMID: 30333516 Free PMC article. Review.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Doebele RC, Drilon A, Paz-Ares L, Siena S, Shaw AT, Farago AF, Blakely CM, Seto T, Cho BC, Tosi D, Besse B, Chawla SP, Bazhenova L, Krauss JC, Chae YK, Barve M, Garrido-Laguna I, Liu SV, Conkling P, John T, Fakih M, Sigal D, Loong HH, Buchschacher GL Jr, Garrido P, Nieva J, Steuer C, Overbeck TR, Bowles DW, Fox E, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Demetri GD; trial investigators. Doebele RC, et al. Lancet Oncol. 2020 Feb;21(2):271-282. doi: 10.1016/S1470-2045(19)30691-6. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838007 Free PMC article.
Foreword.
Hyman DM, Ladanyi M. Hyman DM, et al. Ann Oncol. 2019 Nov;30 Suppl 8(Suppl 8):viii1-viii2. doi: 10.1093/annonc/mdz409. Epub 2019 Dec 24. Ann Oncol. 2019. PMID: 32223933 Free PMC article. No abstract available.
Nerve growth factor and pain.
Wood JN. Wood JN. N Engl J Med. 2010 Oct 14;363(16):1572-3. doi: 10.1056/NEJMe1004416. Epub 2010 Sep 29. N Engl J Med. 2010. PMID: 20942675 No abstract available.
Trk receptors.
Deinhardt K, Chao MV. Deinhardt K, et al. Handb Exp Pharmacol. 2014;220:103-19. doi: 10.1007/978-3-642-45106-5_5. Handb Exp Pharmacol. 2014. PMID: 24668471 Review.
Nerve growth factor receptors and signaling in breast cancer.
Dollé L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H. Dollé L, et al. Curr Cancer Drug Targets. 2004 Sep;4(6):463-70. doi: 10.2174/1568009043332853. Curr Cancer Drug Targets. 2004. PMID: 15379632 Review.
Nerve growth factor: structure and function.
Wiesmann C, de Vos AM. Wiesmann C, et al. Cell Mol Life Sci. 2001 May;58(5-6):748-59. doi: 10.1007/pl00000898. Cell Mol Life Sci. 2001. PMID: 11437236 Review.
Nerve growth factor revisited.
Bradshaw RA, Blundell TL, Lapatto R, McDonald NQ, Murray-Rust J. Bradshaw RA, et al. Trends Biochem Sci. 1993 Feb;18(2):48-52. doi: 10.1016/0968-0004(93)90052-o. Trends Biochem Sci. 1993. PMID: 8488558 Review.
BDNF and Hippocampal Synaptic Plasticity.
Leal G, Bramham CR, Duarte CB. Leal G, et al. Vitam Horm. 2017;104:153-195. doi: 10.1016/bs.vh.2016.10.004. Epub 2016 Nov 29. Vitam Horm. 2017. PMID: 28215294 Review.
1,461 results